Vaccine Overview and Resources
In anticipation of an in-person fall 2021, Cabrini University is requiring all faculty, staff, and students to be fully vaccinated by August 15, 2021. For more information, please visit our COVID-19 Campus Protocols pages on the vaccination requirement, available at cabrini.edu/COVIDvax.
Where can I get vaccinated?
All Pennsylvanians age 12 and older are eligible to receive a COVID-19 vaccine. The PA Department of Health is now using Vaccines.gov as the mapping source to help individuals find a location where they can get vaccinated.
For more on COVID-19 vaccines, including how they work, please see our COVID-19 Vaccine FAQs.
The health and safety of our students and staff is always our top priority. The COVID-19 vaccine, which has gone through testing and clinical trials to ensure it meets the highest safety standards, protects those vaccinated against the COVID-19 illness and, in particular, the most serious and life-threatening symptoms of COVID-19.
Please note, vaccinations are free to obtain and do not require health insurance.
Achieving herd immunity requires a 60% to 70% vaccination rate; achieving this level of vaccination would protect our community against future cases and potential outbreaks—and is one step closer to a return to the “normalcy” of pre-COVID times.
The most prevalent vaccines available have been provided by three companies: Moderna, Pfizer-BioNTech (Pfizer), and Johnson & Johnson Janssen (Johnson & Johnson or J&J). The Moderna and Pfizer vaccines require two shots, and maximum immunity is reached two weeks after the second shot. The J&J vaccine is administered in one shot, with maximum immunity reached two weeks following.
Johnson & Johnson vaccine and adverse side effects
The CDC recently advised that use of the J&J vaccine resume, following a temporary pause after six recipients experienced a rare blood-clotting disorder (thrombosis with thrombocytopenia syndrome, or TTS) following injection. According to the CDC, “a review of all available data at this time shows that the J&J/Janssen COVID-19 Vaccine’s known and potential benefits outweigh its known and potential risks.”
More than 6.8 million people have received the J&J vaccine in the United States alone, and the vast majority experienced no or mild side effects.
The six women, all between the ages of 18 and 48, who developed TTS indicated onset within one to three weeks of vaccination.
The risks are extremely low of severe complication, but you can and should be aware of what to do. If you experience severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, contact your healthcare provider. If it has been longer than three weeks, continue to monitor yourself and report any abnormal issues to your healthcare provider.
Additional COVID-19 Vaccine Resources
CDC Vaccine Resource and Guidance